Press Release: Centrose : Centrose Llc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Study Released

(PR-inside.com) centrose llc (Centrose) is a biotechnology company. The company develops medicines, which selectively target diseased tissues. Its product pipeline includes EDC1 (Dysadherin), EDC2 (CD147), EDC3 (CD98), EDC5 (CD44), and EDC8 (CD38). Centrose's product EDC1 combines two proteins (NKA and Dysadherin) that are found in close proximity to treat cancer cell types. The company's EDC5 targets the cell surface of cancer cells that is responsible for recirculation, homing, multi-drug resistance, lymphocyte activation, and metastasis of many solid tumors. Its Extracellular Drug Conjugate System (EDC) consists of three parts: a drug, a binding component that specifically targets diseased cells, and a linker ..